What You Should Know:
- Spectrum Solutions, LLC announced the publishing of findings from their research collaboration with the University of California at Los Angeles (UCLA) and Dr. David Wong, UCLA School of Dentistry that successfully demonstrated a superior ability to detect circulating tumor DNA (ctDNA) from saliva.
- Specifically, amplified EGFR mutations associated with non-small cell lung cancer (NSCLC) using Spectrum’s saliva collection and preservation system with the Electric
Read More
dna
What to Know About Gene Therapy
Gene therapy is making a world where cancer and AIDS can be cured, and a person can alter their genetic makeup, changing the direction of their own and their offspring's evolution in the process. However, the effects of gene therapy are long-lasting, and may impact both your and the health of your future children.
What Is Gene Therapy?
Utilizing a gene or genes to treat or cure a disease or medical condition is known as gene therapy. Gene therapy frequently involves replacing a
Read More
Watchmaker Genomics Raises $40M to Expand Clinical Sequencing Product Offerings
What You Should Know:
- Watchmaker Genomics, a life sciences company specializing in the development of high-stringency applications focused on the reading, writing, and editing of DNA and RNA raises $40M in an oversubscribed Series A, bringing total funding to date to $53.5M. The round was led by Decheng Capital, with co-investment from Eclipse Ventures.
- Watchmaker Genomics applies advanced enzymology to enable breakthrough applications for the reading, writing, and
Read More
Phenomix Sciences Launches Obesity Biobanking Registry Studying Personalized Treatment Options Based on Genetics
What You Should Know:
- Biotech company Phenomix Sciences launches its biobanking registry, marking the first obesity registry to study the impact of personalized treatment based on phenotyping. The impact of this biobanking registry and the data it will yield has the potential to change the entire system’s approach to obesity, from a treatment recommendation to the way payers determine coverage and how the industry combines diagnostics testing with drug therapy.
- The
Read More
Genetics Startup Pleno Launches Out of Stealth with $15M
What You Should Know:
- Pleno, a multi-omics startup, is emerging out of stealth with a $15M Pre-Series A financing and Greg Lucier as Chairman of the Board of Directors. Founded by Pieter van Rooyen, a well-known biotech engineer who built and sold his last company, Edico Genome, to Illumina for $100M. Edico's Dragen technology has become a staple in genetics research.
- Pleno's Hypercoding technology has the potential to revolutionize biological target detection for
Read More
Seven Bridges, USP, Google Cloud to Build A Brazilian Reference Genome
What You Should Know:
- Seven Bridges, a bioinformatics ecosystem provider, announced it is collaborating with the University of São Paulo (USP) and Google Cloud, as well as the Associação Genomas Brasil (Brazil Genome Association), to assist the DNA do Brasil (DNABr) project in building a reference genome that represents the genetic diversity of the Brazilian population.
- The joint effort will advance unbiased precision medicine for underrepresented populations in Brazil through the
Read More
Blackrock Neurotech Acquires Spatial Computing Firm MindX
What You Should Know:
Blackrock Neurotech, a provider of Brain Computer Interface (BCI) technology, has acquired the spatial computing software house, MindX. Financial details of the acquisition were not disclosed.
- MindX’s spatial computing technology is used to recognize and interpret the movement of objects in physical space, and in combination with Blackrock’s BCI technology, will unlock additional levels of interaction between patients and their physical
Read More
Potential of Implementing Polygenic Risk Scores in Healthcare Systems
The promise of personalized medicine is a world in which interventions, screening, and therapeutics are targeted to those most likely to get the disease. Polygenic risk scores will help society reach this ambition by accurately assessing the contribution that one’s DNA makes to disease risk.
When Thomas Jefferson wrote in the Declaration of Independence that ‘all men are created equal,’ he captured the essential concept of equality on which the US Constitution is based. Although no one would
Read More
Reema Health Secures $8M for Personalized, Community-Based Health Platform
What You Should Know:
- Reema Health, a Minneapolis, MN-based community-based health technology platform raises $8M in seed funding led by MaC Venture Capital and DNA Capital. Combined with a previous $1.25 million pre-seed round and earlier preliminary investments, Reema’s has raised over $10 million to date.
- Reema uses technology to power human relationships with the goal of improving health outcomes for people who are hardest to reach. Reema’s breakthrough health
Read More
BillionToOne Raises $125M to Expand Genetic Testing Platform
What You Should Know:
- BillionToOne, a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all raises $125M in Series C funding co-led by Adams Street Partners and existing investor Hummingbird Ventures with significant participation from Baillie Gifford, Neotribe Ventures, Norwest Venture Partners, Civilization Ventures, Fifty Years VC, Pacific 8 Ventures, Time BioVentures, and Libertus Capital, among others.
- This
Read More
